Metabolic syndrome and dementia associated with Parkinson's disease: Impact of age and hypertension;Síndrome metabólica e demência associada à doença de parkinson: Impacto da idade e da hipertensão arterial

Arquivos de Neuro-Psiquiatria

Volumn 70, Issue 2, 2012, Pages 114-118

  Schelp, Arthur Oscar ^a   Mendes Chiloff, Cristiane Lara ^a   Bazan, Rodrigo ^a   Paduan, Vanessa Cristina ^a   Pioltini, Ana Beatriz Maringolo ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Dementia; Dyslipidemia; Hypertension; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; PARKINSON DISEASE;

EID: 84856907497     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2012000200008     Document Type: Article

References (25)

1. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
2. Levy G, Schupf N, Tang MX, et al. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 2002;51:722-729.
3. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson's disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
4. Uc EY, McDermott MP, Marder KS, et al. Incidence of and risk factors for cognitive impairment in an early Parkinson's disease clinical trial cohort. Neurology 2009;73:1469-1477.
5. Marder KS, Tang MX, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995;52:695-701.
6. Simon, KC, Chen,H, Schwartzchil M, Ascherio A. Hypertension, hypercholesterolemia, diabetes and risk of Parkinson's disease. Neurology 2007;69:1688-1695.
7. Lau LM, Koudstaal PJ, Hoffmann A, Breteler MM. Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol 2006;164:998-1002.
8. Parkes JD, Marsden CD, Rees JE, et al. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q J Med 1974;169:49-61.
9. Yoshimura M. Pathological basis for dementia in elderly patients with idiophatic Parkinson's disease. Eur Neurol 1988; 28 (Suppl 1): S29-S35.
10. Hughes AJ, Bem-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
11. Nitrini R, Caramelli P, Herrera Júnior E, et al. Performance of illiterate and literate nondemented elderly subjects in two tests of long-term-memory. J Int Neuropsychol Soc 2004;10:634-638.
12. Royall DR, Cordes JA, Polk M. Clox: an executive clock drawing task. J Neurol Neurosurg Psychiatry 1998;64:588-594.
13. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB (Eds). Geriatric Psychiatry. New York: Grune & Stratton; 1976:77-121.
14. Porto CS, Fichman HC, Caramelli P, Bahia VS, Nitrini R. Brazilian version of the Mattis dementia rating scale: diagnosis of mild dementia in Alzhemier's disease. Arq Neuropsiquiatr 2003;61:339-345.
15. Dubois B, Boller F, Pillon B, Agid Y. Cognitive deficits in Parkinson's disease. In: Boller F, Grafman J (Eds). Handbook of Neuropsychology. Amsterdam: Elsevier Science Publishers; 1991: 195-240.
16. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102.
17. Rosário TM, Scala LC, França GV, Pereira MR, Jardim PC. Prevalence, control and treatment of arterial hypertension in Nobres - MT. Arq Bras Cardiol 2009;93:622-628.
18. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002;58:1175-1181.
19. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992;49:492-497.
20. Martilla RJ, Rinne UK. Dementia in Parkinson's disease. Acta Neurol Scand 1976;54:431-441.
21. Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54:1596-1602.
22. Levy G, Tang MX, Cote LJ, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 2000;55:539-544.
23. Levy G. The relationship of Parkinson's disease with aging. Arch Neurol 2007;64:1242-1246.
24. Matioli MN, Caramelli P. Limitations in differentiating vascular dementia from Alzheimer's disease with brief cognitive tests. Arq Neuropsiquiatr 2010;68:185-188.
25. Pressley JC, Louis ED, Tang MX, et al. The impact of comorbid diseases and injuries on resource use and expenditures in parkinsonism. Neurology 2003;60:87-93.